0001493152-23-020797.txt : 20230609
0001493152-23-020797.hdr.sgml : 20230609
20230609180021
ACCESSION NUMBER: 0001493152-23-020797
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230607
FILED AS OF DATE: 20230609
DATE AS OF CHANGE: 20230609
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: EAGLE CRAIG
CENTRAL INDEX KEY: 0001562135
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36268
FILM NUMBER: 231006601
MAIL ADDRESS:
STREET 1: POST OFFICE BOX 4590
CITY: NEW YORK
STATE: NY
ZIP: 10163
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: MyMD Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001321834
STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
IRS NUMBER: 000000000
STATE OF INCORPORATION: NJ
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 855 N. WOLFE STREET
STREET 2: SUITE 623
CITY: BALTIMORE
STATE: MD
ZIP: 21205
BUSINESS PHONE: 856-848-8698
MAIL ADDRESS:
STREET 1: 855 N. WOLFE STREET
STREET 2: SUITE 623
CITY: BALTIMORE
STATE: MD
ZIP: 21205
FORMER COMPANY:
FORMER CONFORMED NAME: Akers Biosciences, Inc.
DATE OF NAME CHANGE: 20170413
FORMER COMPANY:
FORMER CONFORMED NAME: Akers Biosciences Inc
DATE OF NAME CHANGE: 20050325
4
1
ownership.xml
X0407
4
2023-06-07
0
0001321834
MyMD Pharmaceuticals, Inc.
MYMD
0001562135
EAGLE CRAIG
855 N. WOLFE STREET,
SUITE 601
BALTIMORE
MD
21205
1
0
0
0
0
Employee Stock Option (Right to Buy)
1.66
2023-06-07
4
A
0
475000
0
A
2028-06-07
Common Stock
475000
475000
D
The stock options vest as follows: (i) one third on the date of grant; (ii) one third on the first anniversary of the date of grant; and (iii) one third on the second anniversary of the date of grant, provided that the Reporting Person remains employed by MyMD Pharmaceuticals, Inc. or a subsidiary on the applicable vesting date.
/s/ Craig Eagle
2023-06-09